|
Status |
Public on Oct 09, 2024 |
Title |
NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing Methylation profiling by array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
39292770 |
|
Submission date |
Mar 11, 2024 |
Last update date |
Oct 10, 2024 |
Contact name |
Esteban Ballestar |
Organization name |
Josep Carreras Research Institute (IJC)
|
Lab |
Epigenetics and Immune Disease
|
Street address |
Ctra de Can Ruti, Camí de les Escoles s/n
|
City |
Badalona, Barcelona |
State/province |
N/A = Not Applicable |
ZIP/Postal code |
08916 |
Country |
Spain |
|
|
Platforms (5)
|
GPL23976 |
Illumina Infinium HumanMethylation850 BeadChip |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
GPL28038 |
DNBSEQ-G400 (Homo sapiens) |
GPL30173 |
NextSeq 2000 (Homo sapiens) |
GPL33022 |
Illumina Infinium MethylationEPIC version 2 |
|
Samples (88)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE261317 |
NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer (DNA methylation I). |
GSE261318 |
NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer (DNA methylation II). |
GSE261321 |
NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer ChIP-Seq). |
GSE261322 |
NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer (RNA-Seq I). |
GSE261323 |
NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer (RNA-Seq II). |
|
Relations |
BioProject |
PRJNA1086485 |